Illumina, Inc. Introduces Two New Benchtop Sequencing Systems
Illumina, Inc. has introduced the MiSeq™ i100 Series, a new line of benchtop sequencing systems designed to enhance laboratories' next-generation sequencing (NGS) capabilities. This series, which includes the MiSeq i100 and MiSeq i100 Plus systems, offers a variety of benefits, providing labs with a streamlined approach to sequencing even for those with minimal NGS expertise.
The MiSeq i100 Series delivers a comprehensive sequencing solution, empowering users to generate valuable insights quickly and efficiently. Both models are designed to simplify sequencing, making it accessible to a broader range of labs, including those with limited technical experience in NGS. The systems are engineered to minimize operational complexity, enabling users to conduct sequencing tasks efficiently.
"The MiSeq i100 symbolizes Illumina's commitment to delivering total systems with complete workflows that allow our customers to accomplish more," said Steve Barnard, PhD, chief technology officer of Illumina. "With its enhanced speed, simplicity, scalability, and quality–and its intuitive user experience–the MiSeq i100 sets a new standard for benchtop sequencing."
Image Credit: Illumina, Inc.
The MiSeq i100 Series delivers a comprehensive sequencing solution, empowering users to generate valuable insights quickly and efficiently. Both models are designed to simplify sequencing, making it accessible to a broader range of labs, including those with limited technical experience in NGS. The systems are engineered to minimize operational complexity, enabling users to conduct sequencing tasks efficiently.
"The MiSeq i100 symbolizes Illumina's commitment to delivering total systems with complete workflows that allow our customers to accomplish more," said Steve Barnard, PhD, chief technology officer of Illumina. "With its enhanced speed, simplicity, scalability, and quality–and its intuitive user experience–the MiSeq i100 sets a new standard for benchtop sequencing."
Image Credit: Illumina, Inc.
Trend Themes
1. Streamlined Sequencing Solutions - The MiSeq i100 Series offers intuitive, easy-to-use sequencing systems that lower the barrier for labs with limited NGS expertise.
2. Enhanced Speed and Efficiency - The new benchtop systems from Illumina, Inc. deliver faster, more efficient sequencing, catering to the growing demand for quick turnaround times in research.
3. Broad Accessibility in NGS - Illumina's latest MiSeq i100 Series broadens NGS accessibility, allowing even minimally-experienced laboratories to perform sequencing with reduced operational complexity.
Industry Implications
1. Biotechnology - Biotech firms can leverage the advanced capabilities of the MiSeq i100 to streamline genomic research and clinical diagnostics.
2. Medical Research - The MiSeq i100 Series provides medical researchers with a powerful tool for conducting efficient and comprehensive genetic studies.
3. Laboratory Equipment - Laboratory equipment suppliers can benefit from offering Illumina's new benchtop sequencing systems to meet the demand for accessible and efficient sequencing solutions.
9.1
Score
Popularity
Activity
Freshness
